<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-14T05:24:34Z</responseDate><request verb="GetRecord" identifier="oai:www.recercat.cat:11351/13017" metadataPrefix="qdc">https://recercat.cat/oai/request</request><GetRecord><record><header><identifier>oai:recercat.cat:11351/13017</identifier><datestamp>2025-10-24T10:26:03Z</datestamp><setSpec>com_2072_378070</setSpec><setSpec>com_2072_378040</setSpec><setSpec>col_2072_378092</setSpec></header><metadata><qdc:qualifieddc xmlns:qdc="http://dspace.org/qualifieddc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://purl.org/dc/elements/1.1/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dc.xsd http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dcterms.xsd http://dspace.org/qualifieddc/ http://www.ukoln.ac.uk/metadata/dcmi/xmlschema/qualifieddc.xsd">
   <dc:title>Sotorasib versus docetaxel for previously treated KRAS G12C-mutated non-small-cell lung cancer: a plain language summary</dc:title>
   <dc:creator>de Langen, Adrianus</dc:creator>
   <dc:creator>Dingemans, Anne-Marie</dc:creator>
   <dc:creator>Pless, Miklos</dc:creator>
   <dc:creator>Johnson, Melissa</dc:creator>
   <dc:creator>MAZIERES, JULIEN</dc:creator>
   <dc:creator>Mountzios, Giannis</dc:creator>
   <dc:creator>FELIP, ENRIQUETA</dc:creator>
   <dc:subject>Anomalies cromosòmiques</dc:subject>
   <dc:subject>Pulmons - Càncer - Tractament</dc:subject>
   <dc:subject>Pulmons - Càncer - Aspectes genètics</dc:subject>
   <dc:subject>Avaluació de resultats (Assistència sanitària)</dc:subject>
   <dc:subject>Medicaments antineoplàstics - Ús terapèutic</dc:subject>
   <dc:subject>PHENOMENA AND PROCESSES::Genetic Phenomena::Genetic Variation::Mutation</dc:subject>
   <dc:subject>DISEASES::Neoplasms::Neoplasms by Site::Thoracic Neoplasms::Respiratory Tract Neoplasms::Lung Neoplasms::Bronchial Neoplasms::Carcinoma, Bronchogenic::Carcinoma, Non-Small-Cell Lung</dc:subject>
   <dc:subject>Other subheadings::Other subheadings::Other subheadings::/drug therapy</dc:subject>
   <dc:subject>CHEMICALS AND DRUGS::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Antineoplastic Agents</dc:subject>
   <dc:subject>Other subheadings::Other subheadings::/therapeutic use</dc:subject>
   <dc:subject>ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Diagnosis::Prognosis::Treatment Outcome</dc:subject>
   <dc:subject>FENÓMENOS Y PROCESOS::fenómenos genéticos::variación genética::mutación</dc:subject>
   <dc:subject>ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias torácicas::neoplasias del tracto respiratorio::neoplasias pulmonares::neoplasias de los bronquios::carcinoma broncogénico::carcinoma de pulmón de células no pequeñas</dc:subject>
   <dc:subject>Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia</dc:subject>
   <dc:subject>COMPUESTOS QUÍMICOS Y DROGAS::acciones y usos químicos::acciones farmacológicas::usos terapéuticos::antineoplásicos</dc:subject>
   <dc:subject>Otros calificadores::Otros calificadores::/uso terapéutico</dc:subject>
   <dc:subject>TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::diagnóstico::pronóstico::resultado del tratamiento</dc:subject>
   <dcterms:abstract>Mutation; Non-small-cell lung cancer</dcterms:abstract>
   <dcterms:abstract>Mutación; Cáncer de pulmón de células no pequeñas</dcterms:abstract>
   <dcterms:abstract>Mutació; Càncer de pulmó de cèl·lules no petites</dcterms:abstract>
   <dcterms:abstract>This manuscript was funded by Amgen Inc.</dcterms:abstract>
   <dcterms:dateAccepted>2025-10-24T10:26:03Z</dcterms:dateAccepted>
   <dcterms:available>2025-10-24T10:26:03Z</dcterms:available>
   <dcterms:created>2025-10-24T10:26:03Z</dcterms:created>
   <dcterms:issued>2025-04-30T06:45:37Z</dcterms:issued>
   <dcterms:issued>2025-04-30T06:45:37Z</dcterms:issued>
   <dcterms:issued>2025</dcterms:issued>
   <dc:type>info:eu-repo/semantics/article</dc:type>
   <dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
   <dc:identifier>http://hdl.handle.net/11351/13017</dc:identifier>
   <dc:relation>Future Oncology;21(9)</dc:relation>
   <dc:relation>https://doi.org/10.1080/14796694.2025.2474789</dc:relation>
   <dc:rights>Attribution-NonCommercial-NoDerivatives 4.0 International</dc:rights>
   <dc:rights>http://creativecommons.org/licenses/by-nc-nd/4.0/</dc:rights>
   <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
   <dc:publisher>Taylor &amp; Francis</dc:publisher>
   <dc:source>Scientia</dc:source>
</qdc:qualifieddc></metadata></record></GetRecord></OAI-PMH>